MicroRNA-361-3p Regulates Autophagy and Apoptotic Processes by Regulating PI3K/Akt Signaling in Parkinson's Disease

Pingting Chen1, Jing Yang2, Yixuan Xu2

  • 1Department of Neurology, Wenling TCM Hospital Affiliated to Zhejiang Chinese Medical University, Taizhou, 317500, China.

PubMed

Insights

MicroRNA-361-3p protects against Parkinson's disease (PD) by reducing cell death and apoptosis. Upregulating this microRNA inhibits PD progression by targeting PFKFB3 and activating the PI3K/Akt pathway.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) play a crucial role in the pathogenesis of Parkinson's disease (PD).
  • Understanding the specific roles of miRNAs in PD is essential for developing targeted therapies.
  • Dysregulation of cellular processes like apoptosis and autophagy is implicated in PD.

Purpose of the Study:

  • To investigate the effect of microRNA (miR)-361-3p on apoptosis and autophagy in a Parkinson's disease (PD) cell model.
  • To elucidate the underlying molecular mechanisms of miR-361-3p in PD pathogenesis.
  • To explore the potential of miR-361-3p as a therapeutic target for PD.

Main Methods:

  • Established an in vitro Parkinson's disease (PD) cell model using SH-SY5Y cells induced by 1-methyl-4-phenylpyridinium ion (MPP+).
  • Manipulated miR-361-3p expression via cell transfection and assessed cell viability (CCK-8), apoptosis (flow cytometry), and inflammatory factors (ELISA).
  • Analyzed autophagy-associated proteins (Beclin 1, LC3) and PI3K/Akt signaling pathway proteins (p-PI3K, p-Akt) using Western blot; verified miR-361-3p target gene (PFKFB3) interaction via luciferase reporter assay.

Main Results:

  • MPP+ treatment decreased miR-361-3p expression and cell viability in a dose-dependent manner.
  • Overexpression of miR-361-3p significantly enhanced cell survival, reduced apoptosis, and modulated autophagy proteins (decreased Beclin 1, LC3II/LC3I ratio) in MPP+-induced cells.
  • miR-361-3p upregulation inhibited PFKFB3 expression, and subsequent PFKFB3 overexpression reversed the protective effects of miR-361-3p, while activating the PI3K/Akt pathway.

Conclusions:

  • miR-361-3p expression is reduced in Parkinson's disease (PD) cell models.
  • Overexpression of miR-361-3p exerts neuroprotective effects by inhibiting apoptosis and modulating autophagy.
  • miR-361-3p functions via regulating PFKFB3 and activating the PI3K/Akt signaling pathway, offering a potential therapeutic strategy for PD.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.3K